Ask AI

The Next Frontier for CDK4/6 Inhibitors in Breast Cancer: Expert Strategies for Applying the Latest Guidelines and Advances in Practice

Enhance your ability to optimally integrate CDK4/6 inhibitors into practice based on current guidelines and expert-recommended best practices to improve outcomes of patients with breast cancer across the disease continuum through a certified on-demand webcast, downloadable slides, expert office hours online forum, and a ClinicalThought commentary.

Share

Program Content

Activities

CDK46i in BC
The Next Frontier for CDK4/6 Inhibitors in Breast Cancer: Expert Strategies for Applying the Latest Guidelines and Advances in Practice
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 29, 2026

Activities

Next Frontier for CDK46
The Next Frontier for CDK4/6 Inhibitors in Breast Cancer: Expert Strategies for Applying the Latest Guidelines and Advances in Practice
Video
Congratulations: You achieved a completion on 04/09/2022

Released: June 26, 2026

Expires: December 25, 2026

Activities

Individualizing CDK46 Inhibitors
FAQs: Individualizing CDK4/6 Inhibitor–Based Therapy in Breast Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 17, 2026

Provided by

ProCE Banner

Provided by the National Comprehensive Cancer Network (NCCN) in collaboration with Decera Clinical Education.

Supporters

Supported by educational grants from Lilly and Novartis.

Lilly

Novartis

Partners

Decera Clinical Education

ProCE Banner